{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:48:32Z","timestamp":1789541312910,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00330-018-5887-z","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T16:28:58Z","timestamp":1546964938000},"page":"2981-2988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-6174","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehwish","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawwaz","family":"Qayyum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heber","family":"MacMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Samuel G.","family":"Armato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"5887_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck AG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumor. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"5887_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"5887_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2214\/ajr.167.4.8819370","volume":"167","author":"KD Hopper","year":"1996","unstructured":"Hopper KD, Kasales CJ, van Slyke MA, Schwartz TA, TenHave TR, Jozefiak JA (1996) Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR Am J Roentgenol 167:851\u2013854","journal-title":"AJR Am J Roentgenol"},{"key":"5887_CR4","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1200\/JCO.1997.15.12.3507","volume":"15","author":"P Thiesse","year":"1997","unstructured":"Thiesse P, Ollivier L, Di Stefano-Louineau D et al (1997) Response rate accuracy in oncology trials: reasons for interobserver variability. J Clin Oncol 15:3507\u20133514","journal-title":"J Clin Oncol"},{"key":"5887_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2478\/v10019-012-0009-z","volume":"46","author":"D Muenzel","year":"2012","unstructured":"Muenzel D, Engels HP, Bruegel M, Kehl V, Rummeny EJ, Metz S (2012) Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1. Radiol Oncol 46:8\u201318","journal-title":"Radiol Oncol"},{"key":"5887_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257\u2013260","journal-title":"Ann Oncol"},{"key":"5887_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1118\/1.1688211","volume":"31","author":"SG Armato 3rd","year":"2004","unstructured":"Armato SG 3rd, Oxnard GR, MacMahon H et al (2004) Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys 31:1105\u20131115","journal-title":"Med Phys"},{"key":"5887_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2214\/AJR.05.0076","volume":"186","author":"SG Armato 3rd","year":"2006","unstructured":"Armato SG 3rd, Ogarek JL, Starkey A et al (2006) Variability in mesothelioma tumor response classification. AJR Am J Roentgenol 186:1000\u20131006","journal-title":"AJR Am J Roentgenol"},{"key":"5887_CR9","doi-asserted-by":"crossref","unstructured":"Armato SG 3rd, Nowak AK, Francis RJ, Kocherginsky M, Byrne MJ (2014) Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions. J Thorac Oncol 9:1187\u20131194","DOI":"10.1097\/JTO.0000000000000211"},{"key":"5887_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1470-2045(15)70056-2","volume":"16","author":"LM Krug","year":"2015","unstructured":"Krug LM, Kindler HL, Calvert H et al (2015) Vorinosat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomized, placebo-controlled trial. Lancet Oncol 16:447\u2013456","journal-title":"Lancet Oncol"},{"key":"5887_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387","journal-title":"Stat Med"},{"key":"5887_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejca.2008.10.031","volume":"45","author":"R Ford","year":"2009","unstructured":"Ford R, Schwartz L, Dancey J et al (2009) Lessons learned from independent central review. Eur J Cancer 45:268\u2013274","journal-title":"Eur J Cancer"},{"key":"5887_CR13","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1200\/JCO.2008.16.1711","volume":"26","author":"LE Dodd","year":"2008","unstructured":"Dodd LE, Korn EL, Freidlin B et al (2008) Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? J Clin Oncol 26:3791\u20133796","journal-title":"J Clin Oncol"},{"key":"5887_CR14","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ejca.2011.02.013","volume":"47","author":"O Amit","year":"2011","unstructured":"Amit O, Mannino F, Stone AM et al (2011) Blinded independent central review of progression in cancer clinical trials: results from a meta-analysis. Eur J Cancer 47:1772\u20131778","journal-title":"Eur J Cancer"},{"key":"5887_CR15","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1200\/JCO.2011.36.4752","volume":"30","author":"RK Jain","year":"2012","unstructured":"Jain RK, Lee JJ, Ng C et al (2012) Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies. J Clin Oncol 30:2684\u20132690","journal-title":"J Clin Oncol"},{"key":"5887_CR16","doi-asserted-by":"crossref","unstructured":"Labby ZE, Armato SG 3rd, Kindler HL, Dignam JJ, Hasani A, Nowak AK (2012) Optimization of response classification criteria for patients with malignant pleural mesothelioma. J Thorac Oncol 7:1728\u20131734","DOI":"10.1097\/JTO.0b013e318269fe21"},{"key":"5887_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","volume":"5","author":"F Liu","year":"2010","unstructured":"Liu F, Zhao B, Krug LM et al (2010) Assessment of therapy response and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans. J Thorac Oncol 5:879\u2013884","journal-title":"J Thorac Oncol"},{"key":"5887_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejrad.2009.02.002","volume":"74","author":"G Ak","year":"2010","unstructured":"Ak G, Metintas M, Metintas S, Yildirim H, Ozkan R, Ozden H (2010) Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma. Eur J Radiol 74:130\u2013135","journal-title":"Eur J Radiol"},{"key":"5887_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2214\/AJR.11.7015","volume":"198","author":"RR Gill","year":"2012","unstructured":"Gill RR, Richards WG, Yeap BY et al (2012) Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol 198:359\u2013363","journal-title":"AJR Am J Roentgenol"},{"key":"5887_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/annonc\/mds535","volume":"24","author":"ZE Labby","year":"2013","unstructured":"Labby ZE, Nowak AK, Dignam JJ, Straus C, Kindler HL, Armato SG 3rd (2013) Disease volumes as a marker for patient response in malignant pleural mesothelioma. Ann Oncol 24:999\u20131005","journal-title":"Ann Oncol"},{"key":"5887_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","volume":"48","author":"RJ Francis","year":"2007","unstructured":"Francis RJ, Byme MJ, van der Schaaf AA et al (2007) Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med 48:1449\u20131458","journal-title":"J Nucl Med"},{"key":"5887_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.lungcan.2015.08.012","volume":"90","author":"L Cheng","year":"2015","unstructured":"Cheng L, Tunariu N, Collins DJ et al (2015) Response evaluation in mesothelioma: beyond RECIST. Lung Cancer 90:433\u2013441","journal-title":"Lung Cancer"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5887-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5887-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5887-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:57:19Z","timestamp":1581965839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5887-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5887"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5887-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Feng Li.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Dr. Armato is a consultant for Aduro Biotech, Inc. Dr. MacMahon is a shareholder of Hologic and a consultant for Riverain Technologies. Drs. Li, Armato, and MacMahon receive royalties and licensing fees for computer-aided diagnosis technology through The University of Chicago. Dr. Kindler is a consultant for Merck and receives research support from Merck.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Retrospective\u2022 Cross sectional study\u2022 Performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}